David Fuller
Directeur Technique/Scientifique/R&D chez DIMERIX LIMITED
Fortune : 1 548 $ au 30/04/2024
Provenance du réseau au premier degré de David Fuller
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 8 | |
| Public Company | Biotechnology | 7 | |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia.
3
| Holding Company | Biotechnology | 3 |
| Public Company | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à David Fuller via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AC IMMUNE SA | Pharmaceuticals: Major | Corporate Officer/Principal | |
iCeutica, Inc.
 iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Founder | |
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Compliance Officer | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Australian National University | College/University | Graduate Degree Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree Masters Business Admin | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ACRUX LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| Manhattan College | College/University | Undergraduate Degree | |
| The University of Queensland | College/University | Doctorate Degree | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Wollongong | College/University | Undergraduate Degree | |
Macquarie Infrastructure Management (Asia) Pty Ltd.
 Macquarie Infrastructure Management (Asia) Pty Ltd. Investment ManagersFinance Macquarie Infrastructure Management (Asia) Pty Ltd. (MIMAL) is a private equity subsidiary of Macquarie Capital Funds Ltd. founded in 2005. The firm is headquartered in Singapore. | Investment Managers | Corporate Officer/Principal | |
| University of Milan | College/University | Doctorate Degree | |
| RMIT University | College/University | Masters Business Admin Graduate Degree | |
| University of Canterbury | College/University | Graduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Hatchtech Pty Ltd.
 Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Pharmaceuticals: Major | President Chief Executive Officer | |
| Royal Australian Chemical Institute, Inc. | Corporate Officer/Principal | ||
Yuuwa Capital Management Pty Ltd.
 Yuuwa Capital Management Pty Ltd. Investment ManagersFinance Yuuwa Capital Management Pty Ltd. ( Yuuwa Capital Management ) is a venture capital firm, founded in 2009 by Liddy McCall , James Williams, Matthew Macfarlane. The firm is headquartered in Bentley, Western Australia. | Investment Managers | Founder | |
| Ear Science Institute of Australia | Director/Board Member | ||
Medicines Development for Global Health Ltd
 Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PolyActiva Pty Ltd.
 PolyActiva Pty Ltd. BiotechnologyHealth Technology PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia. | Biotechnology | Director/Board Member | |
| Argus Biomedical Pty Ltd. | Founder | ||
| Presbyterian Ladies College | College/University | Undergraduate Degree | |
Nexgen Plants Pty Ltd.
 Nexgen Plants Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Nexgen Plants Pty Ltd. develops anti-viral technology solutions that enables virus resistant plant varieties to be developed for major food, fibre, energy and ornamental crops. The company was founded in 2013 and is headquartered in St. Lucia, Australia. | Miscellaneous Commercial Services | Director/Board Member | |
| AMPLIA THERAPEUTICS LIMITED | Biotechnology | Director/Board Member Director of Finance/CFO | |
Gordiantec Pty Ltd.
 Gordiantec Pty Ltd. Packaged SoftwareTechnology Services Gordiantec Pty Ltd. offers genetics research. The company is headquartered in Bentley, Australia. | Packaged Software | Director/Board Member | |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
| Pace Law School | College/University | Graduate Degree | |
| The University of Western Australia Business School | College/University | Undergraduate Degree | |
| BioLab Australia Pty Ltd. | Corporate Officer/Principal | ||
Agworld Pty Ltd.
 Agworld Pty Ltd. Data Processing ServicesTechnology Services Agworld Pty Ltd. farm management solutions. It offers crop production plans, geospatial data interrogation, agronomist recommendations, and financial and crop performance reporting. The company was founded by Matthew Powell, Doug Fitch and Chris Ramsey on December 8, 2009 and is headquartered in West Leederville, Australia. | Data Processing Services | Director/Board Member | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ICETANA LIMITED | Packaged Software | Director/Board Member Director/Board Member | |
Yuuwa Capital LP
 Yuuwa Capital LP Investment ManagersFinance Yuuwa Capital LP seeks investment opportunities in the companies located in Australia primarily in Perth. The fund focuses on companies operating in the fields of software, information & communications technology ventures, life sciences and biotech sectors. It provides financing for early & seed stage capital requirements with investment size ranges between $1 million to $5 million. | Investment Managers | Founder | |
BlueSphere Bio, Inc.
 BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
| HERAMED LIMITED | Packaged Software | Director of Finance/CFO | |
| PKF Sydney Pty Ltd. | Corporate Officer/Principal | ||
| ISLAND PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Chairman Corporate Secretary | |
| ARGENICA THERAPEUTICS LIMITED | Biotechnology | Director/Board Member | |
| Supertrans Medical Ltd. | Director/Board Member | ||
Bio101 Financial Advisory Pty Ltd.
 Bio101 Financial Advisory Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Bio101 Financial Advisory Pty Ltd. provides bookkeeping, strategic financial advice, and administrative services. The private company is based in Camberwell, Australia. The CEO of the Australian company is Cameron Peter Jones. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
The Tailor Made Spirits Co., Ltd.
 The Tailor Made Spirits Co., Ltd. Beverages: AlcoholicConsumer Non-Durables The Tailor Made Spirits Co., Ltd. is a private company headquartered in Osborne Park, Australia. The firm manufactures and sells distillers through online. | Beverages: Alcoholic | Director/Board Member | |
Chartered Accountants Australia & New Zealand
 Chartered Accountants Australia & New Zealand Miscellaneous Commercial ServicesCommercial Services Chartered Accountants Australia & New Zealand is an association for chartered accountants that provides accounting services. The non-profit company is based in Auckland, New Zealand. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistiques
Internationale
| Australie | 34 |
| Etats-Unis | 7 |
| Suisse | 4 |
| Royaume-Uni | 4 |
| Singapour | 2 |
Sectorielle
| Consumer Services | 16 |
| Health Technology | 15 |
| Commercial Services | 5 |
| Technology Services | 5 |
| Finance | 4 |
Opérationnelle
| Director/Board Member | 52 |
| Corporate Officer/Principal | 32 |
| Undergraduate Degree | 13 |
| Chief Executive Officer | 12 |
| Founder | 9 |
Relations les plus connectées
| Insiders | |
|---|---|
| McCall Liddy | 20 |
| Paul MacLeman | 19 |
| Timothy Oldham | 15 |
| Hugh Alsop | 13 |
| Cameron Jones | 11 |
| Robert Peach | 9 |
| Mark Diamond | 7 |
| Sonia Maria Poli | 7 |
| Nina Webster | 7 |
| Keir Loiacono | 6 |
| Hamish George | 5 |
| Michael Kelso | 5 |
| Christina Manfre | 4 |
| Ash Soman | 4 |
| Clinton Snow | 4 |
- Bourse
- Insiders
- David Fuller
- Connexions Sociétés